Companies:
49,742
Total Market Cap:
136733364380208.96
Global Rank
#35913
Country Rank
#2297
Market Cap
20.54 M
Price
3.92
Change (%)
0.37%
Volume
11,546
MiCo BioMed's latest marketcap:
20.54 M
As of 06/26/2025, MiCo BioMed's market capitalization has reached $20.54 M. According to our data, MiCo BioMed is the 35913th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 20.54 M |
| Revenue (ttm) | 3.36 M |
| Net Income (ttm) | -20,285,975.03 |
| Shares Out | 5.15 M |
| EPS (ttm) | -4.45 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Market Cap Chart
Data Updated: 06/26/2025
MiCo BioMed's yearly market capitalization.
MiCo BioMed has seen its market value drop from ₩63.72 B to ₩20.54 M since 2017, representing a total decrease of 99.97% and an annual compound decline rate (CAGR) of 65.79%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩20.54 M | -54.81% | 35913 |
| 12/30/2024 | ₩60.85 B | -24.58% | 29412 |
| 12/28/2023 | ₩80.68 B | -8.17% | 26329 |
| 12/29/2022 | ₩87.86 B | -47.23% | 24655 |
| 12/30/2021 | ₩166.5 B | -18.46% | 20991 |
| 12/30/2020 | ₩204.21 B | 148.32% | 17111 |
| 12/30/2019 | ₩82.23 B | 2.48% | 19961 |
| 12/28/2018 | ₩80.24 B | 25.92% | 19056 |
| 12/28/2017 | ₩63.72 B | 20666 |
Company Profile
About MiCo BioMed Co., Ltd.
MiCo BioMed Co., Ltd. specializes in on-site diagnostic systems utilizing innovative Lab-on-a-Chip technology. Founded in 2009 and headquartered in Seongnam-si, South Korea, the company was formerly known as MiCo NanoBioSys Co., Ltd. before rebranding in March 2018.
Product Offerings
-
Molecular Diagnostics Devices
- Veri-Q PREP M16 (G2-16TU) – Nucleic acid extraction system with membrane technology
- VERI-Q PCR 316 – Rapid-result plastic chip-based device
- VERI-Q PCR 204 (G2-4) – Real-time PCR system
- PCR and sample prep kits, LabChip, sample tubes, and pre-filtering columns
-
Biological Chemistry Products
- VERI-Q Multi – Cholesterol diagnostic solution
- VERI-Q Hb Mate & VERI-Q RED – Hemoglobin monitoring systems
- VERI-Q PRO – Blood glucose monitoring system
-
Immunodiagnostics Products
- VERI-Q COVID-19 Ag Rapid Test & IgGIgM Rapid Test – COVID-19 detection
- VERI-Q PinoView – Disease marker detection via antigen-antibody reaction
- Opti96 ELISA plate/Kit
Frequently Asked Questions
-
What is MiCo BioMed's (KOSDAQ-214610) current market cap?As of 06/26/2025, MiCo BioMed (including the parent company, if applicable) has an estimated market capitalization of $20.54 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does MiCo BioMed (KOSDAQ-214610) rank globally by market cap?MiCo BioMed global market capitalization ranking is approximately 35913 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.